title: When should we consider transplantation in adult patients with sclerosing cholangitis due to multisystem Langerhans' cell histiocytosis?
authors.affiliation: Department of Digestive and Hepatobiliary Diseases, University Hospital Estaing of Clermont-Ferrand, Clermont-Ferrand, France. Electronic address: jscanzi@chu-clermontferrand.fr.
authors.forename: Julien
authors.initials: J
authors.lastname: Scanzi
authors.affiliation: Department of Digestive and Hepatobiliary Diseases, University Hospital Estaing of Clermont-Ferrand, Clermont-Ferrand, France.
authors.forename: Marion
authors.initials: M
authors.lastname: Goutte
authors.affiliation: Department of Digestive and Hepatobiliary Diseases, University Hospital Estaing of Clermont-Ferrand, Clermont-Ferrand, France.
authors.forename: Camille
authors.initials: C
authors.lastname: Teilhet
authors.affiliation: Department of Digestive and Hepatobiliary Diseases, University Hospital Estaing of Clermont-Ferrand, Clermont-Ferrand, France.
authors.forename: Armand
authors.initials: A
authors.lastname: Abergel
mesh_terms: D015209:Cholangitis, Sclerosing / Q000209:etiology*; D017809:Fatal Outcome; D006646:Histiocytosis, Langerhans-Cell / Q000150:complications*; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000209:etiology / Q000601:surgery*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D013997:Time Factors